Endo Pharmaceuticals VP of Finance Salary | Comparably
Endo Pharmaceuticals Claimed Company
"Endo develops and markets drugs and devices for urology, endocrinology and oncology." read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
141
HR or Marketing? Claim Your Free Employer Account

Endo Pharmaceuticals VP of Finance Salary

The average Endo Pharmaceuticals VP of Finance earns an estimated $162,462 annually. Endo Pharmaceuticals' VP of Finance compensation is $44,068 less than the US average for a VP of Finance.

The Finance Department at Endo Pharmaceuticals earns $18,559 more on average than the Customer Support Department.

Last updated 7 months ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$162,462
Average Compensation
$162,462
avg. base

VP of Finance Salaries at Endo Pharmaceuticals

VPs of Finance earn $49,849 more than Accounting Managers.

Accounting Manager
$113k*
Financial Analyst
$88k*
Senior Accountant
$88k*
Business Analyst
$85k*
Accountant
$66k*
* estimated salary

Compensation at Endo Pharmaceuticals by Department

The Finance Department averages $18,559 more than the Customer Support Department, and $6,649 less than the Operations Department

Operations
$87,401 Avg. total comp.
+$7k
Finance
$80,752 Avg. total comp.
Customer Support
$62,193 Avg. total comp.
-$19k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to Endo Pharmaceuticals reported making $231,000, while the average male VP of Finance at similar sized companies reported making $214,467.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to Endo Pharmaceuticals reported making $223,611, while the average Asian or Pacific Islander VP of Finance at similar sized companies reported making $176,500.

How VPs of Finance at Endo Pharmaceuticals Rate Their Compensation

The majority of VPs of Finance at Endo Pharmaceuticals believe they're compensated fairly. 100% of VPs of Finance at Endo Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Endo Pharmaceuticals

×
Rate your company